PF 03463275

PF 03463275 Suppliers list
Company Name: BOC Sciences  
Tel: 1-631-485-4226; 16314854226
Email: info@bocsci.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Rechem science Co., Ltd.  
Tel: 021-31433387 15618786686
Email: sales@rechemscience.com
Company Name: Beijing Solarbio Science & Tecnology Co., Ltd.  
Tel: 17801761073 18101056239
Email: 3193328036@qq.com

PF 03463275 manufacturers

  • PF-03463275
  • PF-03463275 pictures
  • $51.00
  • 2026-05-06
  • CAS:1173239-39-8
  • Purity: 99.95%
  • Supply Ability: 10g
PF 03463275 Basic information
Product Name:PF 03463275
Synonyms:PF0346275;1H-Imidazole-4-carboxamide, N-[(3-chloro-4-fluorophenyl)methyl]-1-methyl-N-[[(1α,5α,6α)-3-methyl-3-azabicyclo[3.1.0]hex-6-yl]methyl]-;PF-03463275, 10 mM in DMSO;1H-Imidazole-4-carboxamide, N-[(3-chloro-4-fluorophenyl)methyl]-1-methyl-N-[[(1α,5α,6α)-3-methyl-3-azabicyclo[3.1.0]hex-6-yl]methyl]-
CAS:1173239-39-8
MF:C19H22ClFN4O
MW:376.86
EINECS:
Product Categories:
Mol File:1173239-39-8.mol
PF 03463275 Structure
PF 03463275 Chemical Properties
Melting point 125 °C
Boiling point 575.8±45.0 °C(Predicted)
density 1.40±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMSO: 33.33 mg/mL (88.44 mM)
pka10.07±0.40(Predicted)
form Solid
color Off-white to light yellow
Safety Information
MSDS Information
PF 03463275 Usage And Synthesis
UsesPF-03463275 is a centrally penetrant, orally available, selective, and competitive GlyT1 (glycine transporter-1) reversible inhibitor, with a Ki of 11.6 nM. PF-03463275 has the potential for Schizophrenia research[1][2].
in vivo

PF-03463275 (1-10 mg/kg; s.c.) attenuates oscillatory potentials (OPs)[2].

Animal Model:Male Sprague-Dawley rats[2]
Dosage:1, 3 and 10 mg/kg
Administration:S.c.
Result:A dose-dependent reduction in the amplitude of oscillatory potentials (OPs) elicited from the dark-adapted rats.
IC 50GlyT1
References[1] Lowe JA 3rd, et al. The discovery of a structurally novel class of inhibitors of the type 1 glycine transporter [published correction appears in Bioorg Med Chem Lett. 2009 Aug 15;19(16):4885. Bronk, Brian S [added]; Schaeffer, Eric [added]]. Bioorg Med Chem Lett. 2009;19(11):2974-2976. DOI:10.1016/j.bmcl.2009.04.035
[2] Liu CN, Pettersen B, Seitis G, Osgood S, Somps C. GlyT1 inhibitor reduces oscillatory potentials of the electroretinogram in rats. Cutan Ocul Toxicol. 2014;33(3):206-211. DOI:10.3109/15569527.2013.833937
PF 03463275 Preparation Products And Raw materials
Tag:PF 03463275(1173239-39-8) Related Product Information
PF-06446846 HYDROCHLORIDE PF-CBP-1.HCl PF 05105679 N-Methyl-N-[2-[[[2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-trifluoromethylpyrimidin-4-yl]amino]methyl]phenyl]methanesulfonamide PF 573228 PF-06882961 6-chloro-5-(4-(1-hydroxycyclobutyl)phenyl)-1H-indole-3-carboxylicacid PF-04979064 PF-3758309 PF-05212384 PF-06281355 PF-562271 Ketohexokinase inhibitor 1 PF-6274484 PF-9366 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide 4-[(Diethylamino)methyl]-N-[2-(2-methoxyphenyl)ethyl]-N-(3R)-3-pyrrolidinylbenzamide 3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione